MYGNMYRIAD GENETICS INCvs its industry peers
A metric-by-metric comparison of MYRIAD GENETICS INC against SIC 2835 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MYGN본 종목 | $301M#3 | — | 1.0x#2 | 0.4x#1 | -1.6%#3 | -188.2%#5 | -47.0%#2 | -120.4%#4 | -76.1%#3 | — | -21.1%#2 | — |
| NTLA | $1.6B#1 | — | 2.5x#4 | 23.1x#5 | 16.9%#2 | 20.5%#3 | -651.7%#4 | -66.5%#3 | — | — | -8.0%#1 | — |
| QDEL | $1.2B#2 | — | 0.6x#1 | 0.4x#2 | -1.9%#4 | 44.8%#2 | -33.7%#1 | -61.1%#2 | -19.8%#1 | — | — | — |
| VNRX | $7M#5 | — | — | 3.9x#3 | 40.0%#1 | 13.4%#4 | -1258.5%#5 | — | — | — | — | — |
| QCLS | $22M#4 | — | 1.1x#3 | 14.2x#4 | -5.3%#5 | 50.2%#1 | -624.4%#3 | -56.1%#1 | -49.5%#2 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2835). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-08-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice